292 related articles for article (PubMed ID: 20368352)
1. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions.
Yuan Z; Villagra A; Peng L; Coppola D; Glozak M; Sotomayor EM; Chen J; Lane WS; Seto E
Mol Cell Biol; 2010 Jun; 30(12):3004-15. PubMed ID: 20368352
[TBL] [Abstract][Full Text] [Related]
2. TRIM29 negatively regulates p53 via inhibition of Tip60.
Sho T; Tsukiyama T; Sato T; Kondo T; Cheng J; Saku T; Asaka M; Hatakeyama S
Biochim Biophys Acta; 2011 Jun; 1813(6):1245-53. PubMed ID: 21463657
[TBL] [Abstract][Full Text] [Related]
3. ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase.
Yang H; Palmbos PL; Wang L; Kim EH; Ney GM; Liu C; Prasad J; Misek DE; Yu X; Ljungman M; Simeone DM
J Biol Chem; 2015 Nov; 290(45):27146-27157. PubMed ID: 26381412
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
[TBL] [Abstract][Full Text] [Related]
5. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein.
Yuan Z; Peng L; Radhakrishnan R; Seto E
J Biol Chem; 2010 Dec; 285(50):39329-38. PubMed ID: 20947501
[TBL] [Abstract][Full Text] [Related]
7. PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth.
Cai W; Su L; Liao L; Liu ZZ; Langbein L; Dulaimi E; Testa JR; Uzzo RG; Zhong Z; Jiang W; Yan Q; Zhang Q; Yang H
Nat Commun; 2019 Dec; 10(1):5800. PubMed ID: 31863007
[TBL] [Abstract][Full Text] [Related]
8. ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells.
Wang L; Yang H; Palmbos PL; Ney G; Detzler TA; Coleman D; Leflein J; Davis M; Zhang M; Tang W; Hicks JK; Helchowski CM; Prasad J; Lawrence TS; Xu L; Yu X; Canman CE; Ljungman M; Simeone DM
Cancer Res; 2014 Mar; 74(6):1778-88. PubMed ID: 24469230
[TBL] [Abstract][Full Text] [Related]
9. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
[TBL] [Abstract][Full Text] [Related]
10. Resistance of mitochondrial p53 to dominant inhibition.
Heyne K; Schmitt K; Mueller D; Armbruester V; Mestres P; Roemer K
Mol Cancer; 2008 Jun; 7():54. PubMed ID: 18547443
[TBL] [Abstract][Full Text] [Related]
11. Sam68 functions as a transcriptional coactivator of the p53 tumor suppressor.
Li N; Richard S
Nucleic Acids Res; 2016 Oct; 44(18):8726-8741. PubMed ID: 27365047
[TBL] [Abstract][Full Text] [Related]
12. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
[TBL] [Abstract][Full Text] [Related]
13. ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3β/Wnt/β-catenin signalling.
Li W; Xue H; Li Y; Li P; Ma F; Liu M; Kong S
Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):845-853. PubMed ID: 31168819
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage.
Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA
Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947
[TBL] [Abstract][Full Text] [Related]
15. ATDC mediates a TP63-regulated basal cancer invasive program.
Palmbos PL; Wang Y; Bankhead Iii A; Kelleher AJ; Wang L; Yang H; Ahmet ML; Gumkowski ER; Welling SD; Magnuson B; Leflein J; Lorenzatti Hiles G; Abel EV; Dziubinski ML; Urs S; Day ML; Ljungman ME; Simeone DM
Oncogene; 2019 May; 38(18):3340-3354. PubMed ID: 30643195
[TBL] [Abstract][Full Text] [Related]
16. ZNF509S1 downregulates PUMA by inhibiting p53K382 acetylation and p53-DNA binding.
Jeon BN; Yoon JH; Han D; Kim MK; Kim Y; Choi SH; Song J; Kim KS; Kim K; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):962-972. PubMed ID: 28757384
[TBL] [Abstract][Full Text] [Related]
17. ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer.
Purohit V; Wang L; Yang H; Li J; Ney GM; Gumkowski ER; Vaidya AJ; Wang A; Bhardwaj A; Zhao E; Dolgalev I; Zamperone A; Abel EV; Magliano MPD; Crawford HC; Diolaiti D; Papagiannakopoulos TY; Lyssiotis CA; Simeone DM
Genes Dev; 2021 Feb; 35(3-4):218-233. PubMed ID: 33446568
[TBL] [Abstract][Full Text] [Related]
18. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.
Tang Y; Luo J; Zhang W; Gu W
Mol Cell; 2006 Dec; 24(6):827-39. PubMed ID: 17189186
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.
McPherson LA; Loktev AV; Weigel RJ
J Biol Chem; 2002 Nov; 277(47):45028-33. PubMed ID: 12226108
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
